CD4 and neoplasm: While the phenotypes of Tregs remain a topic of debate, CD4+ CD25hi Tregs are widely recognized for their potent immunosuppressive activity and their role in fostering tumor progression through inhibition of anti-tumor immune responses, potentially conflicting with the conclusions drawn in our study.